Literature DB >> 32190837

Emerging Trends in Antibiotic Resistant Neisseria gonorrhoeae: A National and Hawai'i Perspective.

Alan R Katz1, Alan Y Komeya2, Jo M Dewater2, Juval E Tomas2, Lance Chinna3, Glenn M Wasserman2.   

Abstract

Gonorrhea is the second most common nationally notifiable infectious disease in the United States. Rates have been increasing nationally as have antibiotic-resistant isolates. Both the Centers for Disease Control and Prevention and the World Health Organization have recognized antibiotic-resistant Neisseria gonorrhoeae as a major public health threat and have warned of the emerging threat of "untreatable" gonorrhea. Hawai'i has been on the front lines nationally for gonococcal antimicrobial susceptibility surveillance due to its long-standing, statewide gonococcal isolate surveillance program coupled with antibiotic susceptibility testing of all isolates, and Hawai'i's geographic location between Asia where drug-resistant strains originate, and the continental United States. This article highlights emerging trends in and current status of antibiotic resistant Neisseria gonorrhoeae from a national and Hawai'i perspective. ©Copyright 2020 by University Health Partners of Hawai‘i (UHP Hawai‘i).

Entities:  

Keywords:  Neisseria gonorrhoeae; drug resistance; microbial

Year:  2020        PMID: 32190837      PMCID: PMC7061027     

Source DB:  PubMed          Journal:  Hawaii J Health Soc Welf        ISSN: 2641-5216


  21 in total

1.  Failure of Dual Antimicrobial Therapy in Treatment of Gonorrhea.

Authors:  Helen Fifer; Usha Natarajan; Lucy Jones; Sarah Alexander; Gwenda Hughes; Daniel Golparian; Magnus Unemo
Journal:  N Engl J Med       Date:  2016-06-23       Impact factor: 91.245

2.  Neisseria gonorrhoeae with high-level resistance to azithromycin: case report of the first isolate identified in the United States.

Authors:  Alan R Katz; Alan Y Komeya; Olusegun O Soge; Mandy I Kiaha; Maria Veneranda C Lee; Glenn M Wasserman; Eloisa V Maningas; A Christian Whelen; Robert D Kirkcaldy; Steven J Shapiro; Gail A Bolan; King K Holmes
Journal:  Clin Infect Dis       Date:  2011-12-19       Impact factor: 9.079

3.  Update to CDC's sexually transmitted diseases treatment guidelines, 2006: fluoroquinolones no longer recommended for treatment of gonococcal infections.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2007-04-13       Impact factor: 17.586

4.  Diversity of isolates of penicillinase-producing Neisseria gonorrhoeae (PPNG) in Honolulu, Hawaii: 1982-1991.

Authors:  S K Sarafian; R J Rice; R G Ohye; H Higa; J S Knapp
Journal:  Sex Transm Dis       Date:  1994 Nov-Dec       Impact factor: 2.830

5.  Sentinel surveillance for antimicrobial resistance in Neisseria gonorrhoeae--United States, 1988-1991. The Gonococcal Isolate Surveillance Project Study Group.

Authors:  R J Gorwitz; A K Nakashima; J S Moran; J S Knapp
Journal:  MMWR CDC Surveill Summ       Date:  1993-08-13

Review 6.  Meeting the public health challenge of multidrug- and extensively drug-resistant Neisseria gonorrhoeae.

Authors:  John W Tapsall; Francis Ndowa; David A Lewis; Magnus Unemo
Journal:  Expert Rev Anti Infect Ther       Date:  2009-09       Impact factor: 5.091

7.  Assessing age-related risk for gonococcal and chlamydial infections among females in Hawaii, 2001: a comparison of morbidity rates with screening test positivity.

Authors:  Alan R Katz; Paul V Effler; Roy G Ohye; Maria Veneranda C Lee
Journal:  Ambul Pediatr       Date:  2004 Mar-Apr

8.  Emerging in vitro resistance to quinolones in penicillinase-producing Neisseria gonorrhoeae strains in Hawaii.

Authors:  J S Knapp; R Ohye; S W Neal; M C Parekh; H Higa; R J Rice
Journal:  Antimicrob Agents Chemother       Date:  1994-09       Impact factor: 5.191

9.  Azithromycin Resistance and Decreased Ceftriaxone Susceptibility in Neisseria gonorrhoeae, Hawaii, USA.

Authors:  John R Papp; A Jeanine Abrams; Evelyn Nash; Alan R Katz; Robert D Kirkcaldy; Norman P O'Connor; Pamela S O'Brien; Derek H Harauchi; Eloisa V Maningas; Olusegun O Soge; Ellen N Kersh; Alan Komeya; Juval E Tomas; Glenn M Wasserman; Gail Y Kunimoto; David L Trees; A Christian Whelen
Journal:  Emerg Infect Dis       Date:  2017-05       Impact factor: 6.883

10.  Detection in the United Kingdom of the Neisseria gonorrhoeae FC428 clone, with ceftriaxone resistance and intermediate resistance to azithromycin, October to December 2018.

Authors:  David W Eyre; Katy Town; Teresa Street; Leanne Barker; Nicholas Sanderson; Michelle J Cole; Hamish Mohammed; Rachel Pitt; Maya Gobin; Charles Irish; Daniel Gardiner; James Sedgwick; Charles Beck; John Saunders; Deborah Turbitt; Clare Cook; Nick Phin; Bavithra Nathan; Paddy Horner; Helen Fifer
Journal:  Euro Surveill       Date:  2019-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.